Tag: Drug Procurement

Moscow plans to further develop offset agreement mechanism

drug development
Offset agreements are a new effective mechanism for public procurement, in which the supplier agrees to establish or upgrade a production facility within the city, while the city authorities agree to purchase the products.

Nacimbio will supply blood plasma product to Russian Ministry of Health

nacimbio
The Russian Ministry of Health will purchase a blood plasma product from Nacimbio, a subsidiary of Rostec Corporation, for more than 1 billion rubles following two auctions held by the Ministry for supply of this medicine.

Kazakhstan makes savings of 18 billion tenge on procurement of medicines

pills
The authorities in Kazakhstan managed to save more than 18 billion tenge on procurement of drugs for the guaranteed amount of free medical care. This was announced by the Minister of Health Elzhan Birtanov.

Russian-made medicines account for up to 72% of public procurement in Russia

pills
In 2017, the public procurement of medicines decreased slightly (with stronger decline in physical rather than monetary terms) and amounted to 340 billion rubles and 0.88 billion packages.

Russia increases its budget for antiretroviral drugs by 20% in 2018

Aids
The Russian Ministry of Health wants to prevent disruptions in the supplies of antiretroviral drugs. This year, the budget of the Ministry allocated 21.6 billion rubles for this purpose.

About 0.5 trillion rubles are allocated for procurement of VED drugs in Russia

medvedev
Notwithstanding the market economy, the state must constantly monitor the prices of medicines, because this issue concerns everyone who lives in Russia

Biocad plans to manufacture 22 new drugs at its new production site

biocad
Biocad will build a plant in Zelenograd Technology Development Special Economic Zone in Moscow, said Dmitry Morozov, the General Director of the company

New preferences for pharmaceutical manufacturers in Russia may take effect in 2019

manufacturing
The Russian government finalized a draft decree for regulating the public procurement of medicines

Availability of vital and essential drugs in Russia is 65% on average

pharmacy
The number of regions in Russia with the availability of vital and essential drugs below the national average level has increased

Kazakhstan plans a phased introduction of regulated prices for all drugs

kazakhstan
The Ministry of Health of the Republic of Kazakhstan elaborated a draft Law in order to improve the regulation in this area and create a patient-oriented drug provision model.

Gilead Sciences allows Belarus to buy medicines at lower prices

belarus
According to Lyudmila Reutskaya, the Head of Department of Pharmaceutical Inspection and Drug Supply Organization, Belarus is included in the list of countries covered by voluntary licensing agreements of Gilead Sciences

Russian Court restricts the authority of FAS for interchangeability of drugs

pills-in-blisters
Today, the procurement of drugs is regulated by the Federal Law FZ-44, under which the state customer has the right to specify INN of the drug and other "product characteristics" in the description of the lot

CapMan Russia fund acquires a 45% stake in Perm-based Medisorb

medisorb
CapMan Russia, a Finnish fund, acquired a 45% stake in Medisorb, a company based in the city of Perm

24 pharmaceutical manufacturers in Kazakhstan are allowed to launch new facilities

kazakhstan flag
24 manufacturers of medicinal products and medical devices in Kazakhstan will be able to launch a new or upgrade their existing production facility

Russian officials will be fined for violating payment term during public procurement

documents signed
Vladimir Putin signed the Federal Law “On Amendments to the Code of Administrative Offenses of the Russian Federation Regarding the Establishment of Administrative Liability of the Customer's Officials

FAS of Russia advocates the “third wheel” rule transformation

documents
Igor Artemyev, the Head of the Federal Antimonopoly Service of Russia, spoke about his agency's position on the current use of “third wheel” rule in public procurement of drugs